Koers Escalon Medical Corp. Nasdaq
Aandelen
US2960743050
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 10,7 mln. 9,99 mln. | Omzet 2023 | 12,18 mln. 11,37 mln. | Marktkapitalisatie | 1,85 mln. 1,73 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 0,14 x |
Nettoschuld 2022 | 611K 571K | Nettoschuld 2023 | 205 191,38 | EV/omzet 2023 | 0,15 x |
K/w-verhouding 2022 |
-28
x | K/w-verhouding 2023 |
8,37
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,1% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 01-11-00 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 01-01-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 01-01-03 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 01-11-00 |
David Jacovini
BRD | Director/Board Member | 48 | 13-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,85% | 216 mld. | |
+9,86% | 190 mld. | |
+31,11% | 152 mld. | |
+34,08% | 113 mld. | |
+1,90% | 64,04 mld. | |
+19,45% | 54,34 mld. | |
+1,63% | 49,21 mld. | |
-3,12% | 39,41 mld. | |
+1,93% | 35,99 mld. |